Edgewise Therapeutics, Inc. Contracts & Agreements
27 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (3)
- Human Resources (7)
- Real Estate (1)
- Uncategorized (8)
- Sales Agreement, dated May 10, 2024, by and between Edgewise Therapeutics, Inc. and Leerink Partners LLC (Filed With SEC on May 10, 2024)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 9, 2024)
- Underwriting Agreement between the Company and Leerink Partners LLC, dated as of January 19, 2024 (Filed With SEC on January 19, 2024)
- Sales Agreement, dated June 16, 2023, by and between Edgewise Therapeutics, Inc. and BofA Securities, Inc (Filed With SEC on June 16, 2023)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 11, 2023)
- Form of Restricted Stock Unit Agreement (Filed With SEC on May 11, 2023)
- 2021 Employee Stock Purchase Plan, as amended, and forms of agreement thereunder (Filed With SEC on February 23, 2023)
- Offer Letter between the Company and Marc Semigran, M.D (Filed With SEC on February 23, 2023)
- Underwriting Agreement, dated as of September 13, 2022, among Edgewise Therapeutics, Inc. and the Representatives (Filed With SEC on September 14, 2022)
- Description of Securities (Filed With SEC on February 24, 2022)
- Offer Letter between the Company and Joanne Donovan, M.D., Ph.D (Filed With SEC on May 13, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 24, 2021)
- Specimen common stock certificate of the Registrant (Filed With SEC on March 22, 2021)
- 2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on March 22, 2021)
- 2021 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on March 22, 2021)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 3, 2020 (Filed With SEC on March 5, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 5, 2021)
- 2017 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on March 5, 2021)
- Offer Letter between the Registrant and Kevin Koch, Ph.D (Filed With SEC on March 5, 2021)
- Offer Letter between the Registrant and Alan Russell, Ph.D (Filed With SEC on March 5, 2021)
- Offer Letter between the Registrant and R. Michael Carruthers (Filed With SEC on March 5, 2021)
- Offer Letter between the Registrant and Behrad Derakhshan, Ph.D (Filed With SEC on March 5, 2021)
- Offer Letter between the Registrant and John Moore (Filed With SEC on March 5, 2021)
- Executive Incentive Compensation Plan (Filed With SEC on March 5, 2021)
- Executive Change in Control and Severance Plan (Filed With SEC on March 5, 2021)
- Outside Director Compensation Policy (Filed With SEC on March 5, 2021)
- Lease between the Registrant and Regents of the University of Colorado, dated July 21, 2020 (Filed With SEC on March 5, 2021)
